A team of French scientists has started clinical trials on humans for a potential HIV/AIDS vaccine.
Chief Scientific Officer at Grenoble-based PX'Therapeutics Nicholas Mouz said: "We're developping a vaccine against HIV, using a protein of the HIV virus called GP41.
"Why the GP41 protein? Because it's a key protein in the mechanism of entry of the virus into the cells.
